Program Schedule

Antimicrobial Resistance from Hell: A Case-based Symposium

Thursday, October 9, 2014: 2:00 PM-3:30 PM
Room: The Pennsylvania Convention Center: Terrace Ballroom-I, II, III, IV

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the epidemiology and manifestations of drug resistant bacterial and fungal pathogens
  • identify management options for emerging multi-drug resistant bacterial and fungal infections via case study

Target Audience: Scientists, Researchers, Pharmacists, Nurses, Microbiologists, Members-in-training, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Health care workers, Fellows, Clinicians, Academicians

Tracks: Pediatric ID, Investigative ID, Global ID, Adult ID

Moderators:  Cesar Arias, MD PhD, University of Texas Medical School At Houston and David Andes, MD, University of Wisconsin

2:00 PM
Gram-positive Super-bugs
George Eliopoulos, MD, FIDSA
2:30 PM
A Gram-negative From Hell
Yehuda Carmeli, MD, MPH
3:00 PM

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 application-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-105-L01-P


C. Arias, Cubist Pharmaceuticals: Consultant and Speaker's Bureau, Consulting fee and Speaker honorarium
Forest Pharmaceuticals: Speaker's Bureau, Speaker honorarium
Pfizer: Grant Investigator and Speaker's Bureau, Research support and Speaker honorarium
Astra-Zeneca: Speaker's Bureau, Speaker honorarium
Novartis, Inc: Speaker's Bureau, Speaker honorarium
Bayer, Inc: Consultant, Consulting fee

D. Andes, Astellas: Consultant and Grant Investigator, Consulting fee and Research grant
Actelion: Grant Investigator, Research grant
Scynexis: Consultant, Consulting fee
Cubist: Consultant and Grant Investigator, Consulting fee and Research grant
Merck: Consultant, Consulting fee

G. Eliopoulos, Cubist: Scientific Advisor, Consulting fee
Rempex: Scientific Advisor, Consulting fee
Durata: Scientific Advisor, Consulting fee

Y. Carmeli, None

J. Baddley, Merck: Consultant, Consulting fee
Astellas: Scientific Advisor, Consulting fee
Pfizer: Data review committee, Consulting fee

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek